DK4071469T3 - Fremgangsmåder til analyse af kromatografidata - Google Patents

Fremgangsmåder til analyse af kromatografidata

Info

Publication number
DK4071469T3
DK4071469T3 DK22169905.1T DK22169905T DK4071469T3 DK 4071469 T3 DK4071469 T3 DK 4071469T3 DK 22169905 T DK22169905 T DK 22169905T DK 4071469 T3 DK4071469 T3 DK 4071469T3
Authority
DK
Denmark
Prior art keywords
analysis
methods
chromatography data
chromatography
data
Prior art date
Application number
DK22169905.1T
Other languages
English (en)
Inventor
Bernhard Schilling
Scott Carver
Stefanie Mcdermott
John Mattila
Hanne Bak
Nathan Mao
Eric Shierly
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60269959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK4071469(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Application granted granted Critical
Publication of DK4071469T3 publication Critical patent/DK4071469T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8603—Signal analysis with integration or differentiation
    • G01N30/8617—Filtering, e.g. Fourier filtering
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8693—Models, e.g. prediction of retention times, method development and validation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/889—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 monitoring the quality of the stationary phase; column performance

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mathematical Physics (AREA)
  • Algebra (AREA)
  • Mathematical Analysis (AREA)
  • Mathematical Optimization (AREA)
  • Pure & Applied Mathematics (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DK22169905.1T 2016-10-25 2017-10-25 Fremgangsmåder til analyse af kromatografidata DK4071469T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662412563P 2016-10-25 2016-10-25
EP17795146.4A EP3532838B1 (en) 2016-10-25 2017-10-25 Methods and systems for chromatography data analysis

Publications (1)

Publication Number Publication Date
DK4071469T3 true DK4071469T3 (da) 2025-06-30

Family

ID=60269959

Family Applications (2)

Application Number Title Priority Date Filing Date
DK22169905.1T DK4071469T3 (da) 2016-10-25 2017-10-25 Fremgangsmåder til analyse af kromatografidata
DK17795146.4T DK3532838T3 (da) 2016-10-25 2017-10-25 Fremgangsmåder og systemer til kromatografidataanalyse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK17795146.4T DK3532838T3 (da) 2016-10-25 2017-10-25 Fremgangsmåder og systemer til kromatografidataanalyse

Country Status (19)

Country Link
US (4) US10613063B2 (da)
EP (3) EP3532838B1 (da)
JP (4) JP7102401B2 (da)
KR (2) KR102759512B1 (da)
CN (3) CN119492842A (da)
AU (3) AU2017350807B2 (da)
BR (1) BR112019006689A2 (da)
CA (1) CA3039788A1 (da)
DK (2) DK4071469T3 (da)
EA (1) EA201990986A1 (da)
ES (2) ES2924060T3 (da)
FI (1) FI4071469T3 (da)
HU (2) HUE072096T2 (da)
IL (5) IL325389A (da)
MX (3) MX2019004316A (da)
PL (2) PL4071469T3 (da)
SG (1) SG11201902667UA (da)
WO (1) WO2018081203A1 (da)
ZA (1) ZA201902257B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017158673A1 (ja) * 2016-03-14 2017-09-21 株式会社島津製作所 質量分析データ解析装置及び質量分析データ解析用プログラム
EA201990986A1 (ru) * 2016-10-25 2019-09-30 Ридженерон Фармасьютикалз, Инк. Способы и системы анализа хроматографических данных
WO2018098502A1 (en) * 2016-11-28 2018-05-31 Board Of Regents, The University Of Texas System Systems, methods and devices for width-based analysis of peak traces
LT3781941T (lt) * 2018-04-20 2026-04-10 Janssen Biotech, Inc. Chromatografijos kolonėlės kvalifikavimas gamybos būduose, skirtuose anti-tnf antikūnų kompozicijoms gaminti
CN109100441B (zh) * 2018-08-23 2021-05-07 西南科技大学 一种液相色谱曲线去除脉冲干扰的方法
JP6791216B2 (ja) * 2018-08-28 2020-11-25 横河電機株式会社 監視プログラム、監視装置、及び監視システム
GB201909274D0 (en) * 2019-06-27 2019-08-14 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
CN110988232A (zh) * 2019-11-28 2020-04-10 南通乐尔环保科技有限公司 一种色谱基线降噪方法及其装置
JP7452186B2 (ja) * 2020-03-30 2024-03-19 東ソー株式会社 クロマトグラフの運転状態の推定方法
JP2023522624A (ja) * 2020-04-14 2023-05-31 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 直交部分最小二乗によるクロマトグラフィ性能の紫外線モニタリング
JP2022091322A (ja) * 2020-12-09 2022-06-21 株式会社島津製作所 液体クロマトグラフのｐＨ管理システムおよびプログラム
US11157644B1 (en) * 2020-12-15 2021-10-26 DataMover LLC Systems and methods of secure networked data exchange
CN112730712B (zh) * 2020-12-31 2022-06-07 杭州谱育科技发展有限公司 提高lc-ms数据信噪比的方法
JP7647205B2 (ja) * 2021-03-17 2025-03-18 東ソー株式会社 精度管理機能を有する液体クロマトグラフィー装置
CN113321817A (zh) * 2021-07-06 2021-08-31 青岛科技大学 一种纳米木质素制备过程关键变量的分析方法
CN117980740A (zh) * 2021-09-28 2024-05-03 默克专利股份有限公司 用于在连续色谱操作过程中监测色谱树脂的方法
JP7779170B2 (ja) * 2022-02-24 2025-12-03 株式会社島津製作所 クロマトグラフ分析装置及びクロマトグラフ分析用プログラム
CN115825313B (zh) * 2023-02-22 2023-04-11 华谱科仪(北京)科技有限公司 色谱信息检测方法、装置、电子设备和计算机可读介质
TW202528736A (zh) 2023-09-08 2025-07-16 美商再生元醫藥公司 用於評估層析管柱完整性的方法及系統

Family Cites Families (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190864A (en) 1986-04-15 1993-03-02 Northeastern University Enzyme amplification by using free enzyme to release enzyme from an immobilized enzyme material
US4801726A (en) 1986-04-15 1989-01-31 Northeastern University Repetitive hit-and-run immunoassay and stable support-analyte conjugates; applied to T-2 toxin
US4937188A (en) 1986-04-15 1990-06-26 Northeastern University Enzyme activity amplification method for increasing assay sensitivity
JPH07111423B2 (ja) * 1986-10-01 1995-11-29 株式会社日立製作所 クロマトグラフのデ−タ処理方法
JPS6486060A (en) * 1987-09-29 1989-03-30 Shimadzu Corp Analysis data processor
US5412083A (en) 1992-04-16 1995-05-02 Northeastern University Carbohydrate heterobifunctional cross-linking reagent
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
WO1996025425A1 (en) 1995-02-16 1996-08-22 Massachusetts Health Research Institute, Inc. Purified tetanus toxoid and toxin
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
JP3180010B2 (ja) * 1995-10-13 2001-06-25 株式会社日立製作所 クロマトグラフ分析装置
KR19990056559A (ko) * 1997-12-29 1999-07-15 윤종용 노이즈 감소방법 및 그 장치
DE69922740T2 (de) 1998-05-11 2005-12-08 Tosoh Corp., Shinnanyo Methode zur Trennung von Nucleinsäuren mittels Flüssigchromatographie
US7303746B2 (en) 1999-06-08 2007-12-04 Regeneron Pharmaceuticals, Inc. Methods of treating eye disorders with modified chimeric polypeptides
US7087411B2 (en) 1999-06-08 2006-08-08 Regeneron Pharmaceuticals, Inc. Fusion protein capable of binding VEGF
US7070959B1 (en) 1999-06-08 2006-07-04 Regeneron Pharmaceuticals, Inc. Modified chimeric polypeptides with improved pharmacokinetic properties
US7306799B2 (en) 1999-06-08 2007-12-11 Regeneron Pharmaceuticals, Inc. Use of VEGF inhibitors for treatment of eye disorders
AU2002213441B2 (en) 2000-10-12 2006-10-26 Genentech, Inc. Reduced-viscosity concentrated protein formulations
US20020064860A1 (en) 2000-11-29 2002-05-30 Schering Corporation Method for purifying adenoviruses
US7101982B2 (en) 2001-03-30 2006-09-05 Immunex Corporation Control of ph transitions during chromatography
US6816789B2 (en) * 2001-04-19 2004-11-09 Varian, Inc. Method and system for analyzing chromatograms
CA2496918A1 (en) 2002-08-28 2004-03-11 Introgen Therapeutics Inc. Chromatographic methods for adenovirus purification
DK1545574T3 (da) 2002-09-13 2014-09-08 Biogen Idec Inc Fremgangsmåde til rensning af polypeptider ved simuleret moving-bed-chromatografi
WO2004087761A1 (ja) 2003-03-31 2004-10-14 Kirin Beer Kabushiki Kaisha ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
CA2529945A1 (en) 2003-06-27 2005-01-06 Biogen Idec Ma Inc. Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
DE602004026343D1 (de) 2003-10-24 2010-05-12 Amgen Inc Verfahren zur aufreinigung von proteinen in einer durchflussfraktion aus der chromatographie mit hydrophoben wechselwirkungen
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
SE0400501D0 (sv) 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
AU2005216847B2 (en) 2004-02-27 2010-04-01 Cytiva Bioprocess R&D Ab A process for the purification of antibodies
SE0400886D0 (sv) 2004-04-02 2004-04-02 Amersham Biosciences Ab Process of purification
WO2006020622A1 (en) 2004-08-09 2006-02-23 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
US7795405B2 (en) 2004-08-09 2010-09-14 Guild Associates, Inc. Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
KR101243601B1 (ko) 2004-10-21 2013-03-20 지이 헬스케어 바이오-사이언시스 에이비 크로마토그래피 리간드
US7303748B2 (en) 2005-02-02 2007-12-04 Regeneron Pharmaceuticals, Inc. Method of treating eye injury with local administration of a VEGF inhibitor
US20080299671A1 (en) 2005-12-02 2008-12-04 Ge Healthcare Bio-Sciences Ab Hydrophobic Interaction Chromatography
WO2007110339A1 (en) 2006-03-28 2007-10-04 F. Hoffmann-La Roche Ag Anti-igf-1r human monoclonal antibody formulation
KR20140071452A (ko) 2006-04-05 2014-06-11 애브비 바이오테크놀로지 리미티드 항체 정제
US7608261B2 (en) 2006-06-16 2009-10-27 Regeneron Pharmacuticals, Inc. VEGF antagonist formulations suitable for intravitreal administration
US9766217B2 (en) 2006-09-08 2017-09-19 Novo Nordisk A/S Methods of optimizing chromatographic separation of polypeptides
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
WO2008109721A1 (en) 2007-03-06 2008-09-12 Introgen Therapeutics, Inc. Chromatographic methods for assessing adenovirus purity
US8003364B2 (en) 2007-05-14 2011-08-23 Bavarian Nordic A/S Purification of vaccinia viruses using hydrophobic interaction chromatography
WO2009058769A1 (en) 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
NZ587161A (en) 2008-01-25 2012-02-24 Biogen Idec Inc Automated system and and method for monitoring chromatography column performance by calculating performance parameters based on noise reduced process values
US7897405B2 (en) 2008-02-11 2011-03-01 Thermo Finnigan Llc Method for identifying the elution time of an analyte
US20090277254A1 (en) * 2008-05-09 2009-11-12 Medlmmune, Llc Methods of improving packed-bed chromatography performance
JP5635509B2 (ja) * 2008-08-15 2014-12-03 バイオジェン・アイデック・エムエイ・インコーポレイテッド クロマトグラフィーカラムの性能を評価するための方法
US20100069617A1 (en) 2008-09-12 2010-03-18 Ge Healthcare Bio-Sciences Ab Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
MX2011004201A (es) 2008-10-20 2011-05-24 Abbott Lab Desactivacion viral durante purificacion de anticuerpos.
AU2009347206C1 (en) 2008-10-20 2016-12-08 Abbvie Inc. Isolation and purification of antibodies using Protein A affinity chromatography
MX2011011772A (es) 2009-05-04 2012-02-08 Abbott Biotech Ltd Formulaicones estables de anticuerpos humanos anti-tnf-alfa con alta concentracion de proteina.
HUE028341T2 (en) 2009-06-16 2016-12-28 Genzyme Corp Improved methods for purification of recombinant aav vectors
WO2011028961A2 (en) 2009-09-04 2011-03-10 Xoma Technology Ltd. Anti-botulism antibody coformulations
ES2813398T3 (es) 2009-10-20 2021-03-23 Abbvie Inc Aislamiento y purificación de anticuerpos anti-IL-13 usando cromatografía de afinidad a Proteína A
US8246833B2 (en) 2009-12-17 2012-08-21 Ge Healthcare Bio-Sciences Ab Chromatography column and maintenance method
JP2013519652A (ja) 2010-02-12 2013-05-30 ディーエスエム アイピー アセッツ ビー．ブイ． 単一ユニット抗体精製
JP5719433B2 (ja) * 2010-06-10 2015-05-20 インターナショナル・ビジネス・マシーンズ・コーポレーションＩｎｔｅｒｎａｔｉｏｎａｌ Ｂｕｓｉｎｅｓｓ Ｍａｃｈｉｎｅｓ Ｃｏｒｐｏｒａｔｉｏｎ 質量スペクトルを分析するための方法、コンピュータ・プログラム、およびシステム
WO2012030512A1 (en) 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
SG190069A1 (en) 2010-11-11 2013-06-28 Abbvie Biotechnology Ltd IMPROVED HIGH CONCENTRATION ANTI-TNFa ANTIBODY LIQUID FORMULATIONS
CA2821711C (en) 2010-12-15 2017-10-10 Baxter International Inc. Eluate collection using conductivity gradient
US20120246211A1 (en) * 2011-03-24 2012-09-27 Lytle Fred E Syntactical system and method for chromatographic peak identification
HUP1100312A2 (en) * 2011-06-14 2013-01-28 Emil Dr Mincsovics Procedure and equipment for improving of performance characteristics of column chromatography separation processes
US9943594B2 (en) 2011-10-11 2018-04-17 Sanofi Biotechnology Methods for the treatment of rheumatoid arthritis
TWI589299B (zh) 2011-10-11 2017-07-01 再生元醫藥公司 用於治療類風濕性關節炎之組成物及其使用方法
US20140288278A1 (en) 2011-10-31 2014-09-25 Joseph Nti-Gyabaah Chromatography process for resolving heterogeneous antibody aggregates
AU2012339722B2 (en) 2011-11-14 2017-09-14 Regeneron Pharmaceuticals, Inc. Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and/or Activin A
EP2782932A1 (en) 2011-11-21 2014-10-01 F.Hoffmann-La Roche Ag Purification of anti-c-met antibodies
ES2690213T3 (es) 2011-12-15 2018-11-19 Prestige Biopharma Pte. Ltd. Un método de purificación de anticuerpos
US20150051843A1 (en) * 2012-01-16 2015-02-19 Leco Corporation Systems and Methods to Process Data in Chromatographic Systems
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US20140154270A1 (en) 2012-05-21 2014-06-05 Chen Wang Purification of non-human antibodies using kosmotropic salt enhanced protein a affinity chromatography
TW201348246A (zh) 2012-05-21 2013-12-01 Abbvie Inc 利用蛋白質ａ親和性層析之人類、人類化或嵌合抗體之新穎純化
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
US8941405B2 (en) 2012-08-03 2015-01-27 International Business Machines Corporation FET pair based physically unclonable function (PUF) circuit with a constant common mode voltage
WO2014025771A2 (en) 2012-08-06 2014-02-13 Biogen Idec Ma Inc. Methods and compositions for inactivating enveloped viruses
US9650411B2 (en) 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
US20150344557A1 (en) 2012-12-20 2015-12-03 Medlmmune, Llc Liquid Antibody Formulation With Improved Aggregation Properties
SG10201709131UA (en) 2013-03-08 2017-12-28 Genzyme Corp Continuous purification of therapeutic proteins
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
CA2926301A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. Low acidic species compositions and methods for producing and using the same
WO2014145744A1 (en) 2013-03-15 2014-09-18 Alder Biopharmaceuticals, Inc. Antibody purification and purity monitoring
DK2970378T3 (da) 2013-03-15 2021-08-23 Biogen Ma Inc Hydrofob interaktionsproteinkromatografi under saltfrie betingelser
HRP20251426T1 (hr) 2013-05-06 2026-01-02 Scholar Rock, Inc. Sastavi i postupci za modulaciju faktora rasta
TWI682780B (zh) 2013-05-30 2020-01-21 美商再生元醫藥公司 醫藥組成物用於製造治療與ｐｃｓｋ９功能獲得性突變有關之體染色體顯性高膽固醇血症的藥物之用途
US10111953B2 (en) 2013-05-30 2018-10-30 Regeneron Pharmaceuticals, Inc. Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
TWI755763B (zh) 2013-06-04 2022-02-21 美商再生元醫藥公司 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
KR101569783B1 (ko) 2013-06-05 2015-11-19 한화케미칼 주식회사 항체의 정제 방법
US9150938B2 (en) 2013-06-12 2015-10-06 Orochem Technologies, Inc. Tagatose production from deproteinized whey and purification by continuous chromatography
AR096713A1 (es) 2013-06-25 2016-01-27 Cadila Healthcare Ltd Proceso de purificación para anticuerpos monoclonales
RU2016112549A (ru) 2013-09-05 2017-10-10 Дженентек, Инк. Способ для повторного использования хроматографии
EP4331605A3 (en) 2013-09-13 2024-05-22 F. Hoffmann-La Roche AG Methods and compositions comprising purified recombinant polypeptides
ES2915378T3 (es) 2013-09-13 2022-06-22 Hoffmann La Roche Procedimientos para detectar y cuantificar una proteína de célula huésped en líneas celulares
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US20160251441A1 (en) 2013-10-25 2016-09-01 Medimmune, Llc Antibody purification
US10115576B2 (en) * 2013-12-12 2018-10-30 Waters Technologies Corporation Method and an apparatus for analyzing a complex sample
CN103616458B (zh) * 2013-12-14 2015-05-27 环境保护部南京环境科学研究所 一种定量检测大气细粒子pm2.5中6种硝基苯类化合物的方法
JP6260351B2 (ja) * 2014-03-04 2018-01-17 株式会社島津製作所 クロマトグラフ用データ処理装置及びデータ処理方法
JO3701B1 (ar) 2014-05-23 2021-01-31 Regeneron Pharma مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي
FR3025515B1 (fr) 2014-09-05 2016-09-09 Lab Francais Du Fractionnement Procede de purification d'un anticorps monoclonal
TW201628649A (zh) 2014-10-09 2016-08-16 再生元醫藥公司 減少醫藥調配物中微可見顆粒之方法
WO2016089886A2 (en) 2014-12-02 2016-06-09 Regeneron Pharmaceuticals, Inc. Methods for treating dry eye disease by administering an il-6r antagonist
EP3247718B1 (en) 2015-01-21 2021-09-01 Outlook Therapeutics, Inc. Modulation of charge variants in a monoclonal antibody composition
TWI710573B (zh) 2015-01-26 2020-11-21 美商再生元醫藥公司 抗伊波拉病毒醣蛋白之人類抗體
CN104748764B (zh) * 2015-04-01 2017-05-24 清华大学 一种声场可视化系统中声像平面的空间角度标定方法
TWI756187B (zh) 2015-10-09 2022-03-01 美商再生元醫藥公司 抗ｌａｇ３抗體及其用途
AU2016378573A1 (en) 2015-12-22 2018-07-19 Regeneron Pharmaceuticals, Inc. Bispecific anti-CD20/anti-CD3 antibodies to treat acute lymphoblastic leukemia
JP7126941B2 (ja) 2015-12-22 2022-08-29 リジェネロン・ファーマシューティカルズ・インコーポレイテッド がんを治療するための抗ｐｄ－１抗体と二重特異性抗ｃｄ２０／抗ｃｄ３抗体の組合せ
EP3184119A1 (en) 2015-12-23 2017-06-28 Themis Bioscience GmbH Chromatography based purification strategies for measles scaffold based viruses
GB201602938D0 (en) 2016-02-19 2016-04-06 Ucb Biopharma Sprl Protein purification
US10353868B2 (en) * 2016-04-11 2019-07-16 RMC Pharmaceutical Solutions, Inc. Methods and systems for event based notifications
US10947262B2 (en) 2016-06-14 2021-03-16 Biogen Ma Inc. Hydrophobic interaction chromatography for purification of oligonucleotides
WO2018027195A1 (en) 2016-08-05 2018-02-08 Abbvie Biotherapeutics Inc. Compositions containing reduced amounts of daclizumab acidic isoforms and methods for preparing the same
EA201990986A1 (ru) * 2016-10-25 2019-09-30 Ридженерон Фармасьютикалз, Инк. Способы и системы анализа хроматографических данных
US10626376B2 (en) 2016-11-14 2020-04-21 St. Jude Children's Research Hospital Method for isolating and purifying adeno-associated virus particles using salt
WO2019040671A1 (en) 2017-08-22 2019-02-28 Biogen Ma Inc. METHODS OF PURIFYING ANTIBODIES HAVING REDUCED AGGREGATES OF HIGH MOLECULAR WEIGHT
WO2019178495A1 (en) 2018-03-16 2019-09-19 Biogen Ma Inc. Methods for purifying recombinant adeno-associated viruses
US12325875B2 (en) 2018-03-16 2025-06-10 Bristol-Myers Squibb Company Metabolic enzyme activity and disulfide bond reduction during protein production
WO2019191416A1 (en) 2018-03-29 2019-10-03 Bristol-Myers Squibb Company Methods of purifying monomeric monoclonal antibodies
CN112566930A (zh) 2018-06-19 2021-03-26 百时美施贵宝公司 使用色谱纯化蛋白质的方法
TWI853823B (zh) 2018-07-02 2024-09-01 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
EP3826743A4 (en) 2018-07-25 2022-09-14 Merck Sharp & Dohme Corp. METHODS FOR SEPARATION OF HOST CELL LIPASES FROM A PRODUCTION PROTEIN IN CHROMATOGRAPHIC METHODS
CN112805300A (zh) 2018-08-15 2021-05-14 百时美施贵宝公司 下游色谱法中依据再氧化的蛋白质片段化控制策略
US20220017570A1 (en) 2018-11-05 2022-01-20 Bristol-Meyers Squibb Company Method for purifying pegylated protein
WO2020172658A1 (en) 2019-02-24 2020-08-27 Bristol-Myers Squibb Company Methods of isolating a protein
EP3948262B1 (en) 2019-03-29 2024-07-17 Bristol-Myers Squibb Company Methods of measuring hydrophobicity of chromatographic resins
EP3990031A4 (en) 2019-06-28 2023-08-09 Takeda Pharmaceutical Company Limited Adeno-associated virus purification methods

Also Published As

Publication number Publication date
CN114858957A (zh) 2022-08-05
JP2022125254A (ja) 2022-08-26
EP3532838A1 (en) 2019-09-04
CA3039788A1 (en) 2018-05-03
IL312194A (en) 2024-06-01
US10613063B2 (en) 2020-04-07
JP2024028600A (ja) 2024-03-04
IL312194B1 (en) 2026-01-01
MX2023009743A (es) 2023-08-30
KR20230119729A (ko) 2023-08-16
EA201990986A1 (ru) 2019-09-30
IL265874A (en) 2019-06-30
AU2024266951A1 (en) 2024-12-19
IL325389A (en) 2026-02-01
IL295211B2 (en) 2024-09-01
FI4071469T3 (fi) 2025-07-17
MX2019004316A (es) 2019-08-05
KR102759512B1 (ko) 2025-02-03
EP4071469A2 (en) 2022-10-12
HUE059631T2 (hu) 2022-12-28
ES3032778T3 (en) 2025-07-24
JP2020500299A (ja) 2020-01-09
PL4071469T3 (pl) 2025-07-28
JP2025161934A (ja) 2025-10-24
IL295211A (en) 2022-10-01
AU2022246438B2 (en) 2024-12-12
CN109923411B (zh) 2022-05-31
BR112019006689A2 (pt) 2019-06-25
IL265874B (en) 2022-02-01
CN114858957B (zh) 2024-11-22
IL295211B1 (en) 2024-05-01
EP4575488A2 (en) 2025-06-25
JP7734769B2 (ja) 2025-09-05
SG11201902667UA (en) 2019-05-30
AU2017350807B2 (en) 2022-07-07
MX2023009744A (es) 2023-08-30
US11680930B2 (en) 2023-06-20
EP4071469A3 (en) 2022-12-14
US20230273163A1 (en) 2023-08-31
WO2018081203A1 (en) 2018-05-03
HUE072096T2 (hu) 2025-10-28
AU2017350807A1 (en) 2019-04-18
CN119492842A (zh) 2025-02-21
KR20190073396A (ko) 2019-06-26
AU2022246438A1 (en) 2022-11-03
IL289895B (en) 2022-09-01
ES2924060T3 (es) 2022-10-04
US11333642B2 (en) 2022-05-17
PL3532838T3 (pl) 2022-10-03
IL289895A (en) 2022-03-01
EP4575488A3 (en) 2025-08-20
JP7427721B2 (ja) 2024-02-05
US20180113101A1 (en) 2018-04-26
DK3532838T3 (da) 2022-07-04
US20200191756A1 (en) 2020-06-18
US20220308025A1 (en) 2022-09-29
CN109923411A (zh) 2019-06-21
KR102564393B1 (ko) 2023-08-08
EP4071469B1 (en) 2025-04-09
JP7102401B2 (ja) 2022-07-19
ZA201902257B (en) 2020-11-25
EP3532838B1 (en) 2022-06-01

Similar Documents

Publication Publication Date Title
DK4071469T3 (da) Fremgangsmåder til analyse af kromatografidata
DK3548652T3 (da) Fremgangsmåder til proteinanalyse
DK3673493T3 (da) Brugerflade til analyse af elektrokardiogrammer
EP3449438A4 (en) Customer experience analytics
DK3077943T3 (da) Fremgangsmåder og systemer til analyse af billeddata
EP3323070A4 (en) Neo-antigen-ANALYSIS
DK3452695T3 (da) Fremgangsmåder og systemer til analyse af hydrauliskfrakturerede reservoirer
DK3882357T3 (da) Fremgangsmåder og sammensætninger til analyse af nukleinsyrer
DK3563156T3 (da) Fremgangsmåde til separering af biomolekyler
DK3110975T3 (da) Fremgangsmåder til analyse af somatiske mobile elementer og anvendelser deraf
DK4206640T3 (da) Mikrotom
DK3497207T3 (da) Fremgangsmåder til påvisning af aav
DK3194612T3 (da) Fremgangsmåder til kvantitativ genetisk analyse af cellefrit dna
DK3436998T3 (da) Instrument til overvågning af en analytkoncentration
DK3171765T3 (da) Indsamling og analyse af data til diagnostiske formål
DK3384274T3 (da) Fremgangsmåder til prøvekarakterisering
DK3792378T3 (da) Fremgangsmåder og anordninger til analyse af partikler
DK3665173T3 (da) Ny fremgangsmåde til yntetisering af amanitiner
DK3412779T3 (da) Fremgangsmåde til påvisning af aviær nekrotisk enteritis
DK3487443T3 (da) Fremgangsmåde til opmåling af en implantat-implantat-situation
DK3237636T3 (da) Dobbelt-quenching analyse til multiplex detektion af målnukleinsyrer
DK3822365T3 (da) Platform til opdagelse og analyse af terapeutiske midler
EP3358346A4 (en) PROCESS FOR ENANTIOMER ANALYSIS
DK3563155T3 (da) Præfabrikeret mikropartikel til udførelse af en påvisning af en analyt
DK3366832T3 (da) Indretning til identifikation af stoftype